Marc Belsky
2015 - Five Prime Therapeutics
In 2015, Marc Belsky earned a total compensation of $2.5M as Senior Vice President and Chief Financial Officer at Five Prime Therapeutics, a 276% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,900 |
|---|---|
| Option Awards | $550,850 |
| Salary | $322,917 |
| Stock Awards | $1,460,941 |
| Other | $6,000 |
| Total | $2,525,608 |
Belsky received $1.5M in stock awards, accounting for 58% of the total pay in 2015.
Belsky also received $184.9K in non-equity incentive plan, $550.9K in option awards, $322.9K in salary and $6K in other compensation.
Rankings
In 2015, Marc Belsky's compensation ranked 3,790th out of 13,638 executives tracked by ExecPay. In other words, Belsky earned more than 72.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,790 out of 13,638 | 72nd |
Division Manufacturing | 1,380 out of 5,190 | 73rd |
Major group Chemicals And Allied Products | 499 out of 1,854 | 73rd |
Industry group Drugs | 400 out of 1,528 | 74th |
Industry Pharmaceutical Preparations | 316 out of 1,182 | 73rd |
Source: SEC filing on March 31, 2017.
Belsky's colleagues
We found three more compensation records of executives who worked with Marc Belsky at Five Prime Therapeutics in 2015.